BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24703580)

  • 21. Obstructive sleep apnea is associated with fatigue in multiple sclerosis.
    Kaminska M; Kimoff RJ; Benedetti A; Robinson A; Bar-Or A; Lapierre Y; Schwartzman K; Trojan DA
    Mult Scler; 2012 Aug; 18(8):1159-69. PubMed ID: 22183937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuropsychological evaluation in multiple sclerosis].
    Arnett P; Forn C
    Rev Neurol; 2007 Feb 1-15; 44(3):166-72. PubMed ID: 17285522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Event related potential and response time give evidence for a physiological reserve in cognitive functioning in relapsing-remitting multiple sclerosis.
    Sundgren M; Wahlin Å; Maurex L; Brismar T
    J Neurol Sci; 2015 Sep; 356(1-2):107-12. PubMed ID: 26117361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscle Fatigability During a Sustained Index Finger Abduction and Depression Scores Are Associated With Perceived Fatigue in Patients With Relapsing-Remitting Multiple Sclerosis.
    Wolkorte R; Heersema DJ; Zijdewind I
    Neurorehabil Neural Repair; 2015 Sep; 29(8):796-802. PubMed ID: 25605633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis.
    Ruet A; Deloire MS; Charré-Morin J; Hamel D; Brochet B
    Mult Scler; 2013 Oct; 19(12):1665-72. PubMed ID: 23459569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between global cognitive decline and depressive symptoms in multiple sclerosis.
    Barwick FH; Arnett PA
    Clin Neuropsychol; 2011 Feb; 25(2):193-209. PubMed ID: 21246447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive deficits in chronic fatigue syndrome and their relationship to psychological status, symptomatology, and everyday functioning.
    Cockshell SJ; Mathias JL
    Neuropsychology; 2013 Mar; 27(2):230-42. PubMed ID: 23527651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.
    Aragona M; Onesti E; Tomassini V; Conte A; Gupta S; Gilio F; Pantano P; Pozzilli C; Inghilleri M
    Clin Neuropharmacol; 2009; 32(1):41-7. PubMed ID: 18978501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive, but not mood dysfunction develops in multiple sclerosis during 7 years of follow-up.
    Haase CG; Tinnefeld M; Daum I; Ganz RE; Haupts M; Faustmann PM
    Eur Neurol; 2004; 52(2):92-5. PubMed ID: 15273430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of neuropsychological impairment and vocational outcomes in systemic lupus erythematosus and multiple sclerosis patients.
    Covey TJ; Shucard JL; Shucard DW; Stegen S; Benedict RH
    J Int Neuropsychol Soc; 2012 May; 18(3):530-40. PubMed ID: 22410107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between fatigue and other clinical features of multiple sclerosis.
    Mills RJ; Young CA
    Mult Scler; 2011 May; 17(5):604-12. PubMed ID: 21135018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
    Amato MP; Portaccio E; Goretti B; Zipoli V; Battaglini M; Bartolozzi ML; Stromillo ML; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
    Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive fatigue during a test requiring sustained attention: a pilot study.
    Schwid SR; Tyler CM; Scheid EA; Weinstein A; Goodman AD; McDermott MP
    Mult Scler; 2003 Oct; 9(5):503-8. PubMed ID: 14582777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detecting cognitive fatigue in multiple sclerosis: method matters.
    Walker LA; Berard JA; Berrigan LI; Rees LM; Freedman MS
    J Neurol Sci; 2012 May; 316(1-2):86-92. PubMed ID: 22336698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reaction time and rapid serial processing measures of information processing speed in multiple sclerosis: complexity, compounding, and augmentation.
    Hughes AJ; Denney DR; Lynch SG
    J Int Neuropsychol Soc; 2011 Nov; 17(6):1113-21. PubMed ID: 22040901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between cognitive impairment and quality of life in patients with early multiple sclerosis.
    Glanz BI; Healy BC; Rintell DJ; Jaffin SK; Bakshi R; Weiner HL
    J Neurol Sci; 2010 Mar; 290(1-2):75-9. PubMed ID: 19944429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating the role of coping style as a moderator of fatigue and risk for future cognitive impairment in multiple sclerosis.
    Ukueberuwa DM; Arnett PA
    J Int Neuropsychol Soc; 2014 Aug; 20(7):751-5. PubMed ID: 24998987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indices of cognitive dysfunction in relapsing-remitting multiple sclerosis: intra-individual variability, processing speed, and attention network efficiency.
    Wojtowicz M; Omisade A; Fisk JD
    J Int Neuropsychol Soc; 2013 May; 19(5):551-8. PubMed ID: 23425598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MSQoL-54 predicts change in fatigue after inpatient rehabilitation for people with multiple sclerosis.
    Drulovic J; Bursac LO; Milojkovic D; Tepavcevic DK; Gazibara T; Pekmezovic T
    Disabil Rehabil; 2013 Mar; 35(5):362-6. PubMed ID: 22897503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.